Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02216500 · ClinicalTrials.gov registry record · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
A NA study of Seizures, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT02216500: Recruiting NA study of Seizures, sponsored by University of Florida.
NCT02216500 is a NA study of Seizures that is actively recruiting participants, run by University of Florida. The registered enrollment target is 400 participants, below the 924-participant average among 39 other Seizures trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02216500, a NA study of Seizures, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is no agreement concerning how it works and what is the best way to administer it. This natural history study will collect data pertaining to both questions.
Primary Outcome
Seizures will be charted from collected data.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ketogenic Therapy
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2006-09 |
| Est. Completion | 2031-10 |
| Phase | NA |
What NCT02216500 shows while recruiting
NCT02216500 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 924-participant average among 39 other Seizures trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Seizures appearing as the primary indexed condition, and to 1 intervention - of which Ketogenic Therapy is the first listed.
NCT02216500 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02216500 about?
NCT02216500 is a clinical study titled "Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy". Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is no agreement concerning how it works and what is the best way to administer it. This natural history study will co...
What is the current status of trial NCT02216500?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2006-09. Estimated completion is 2031-10.
What conditions does trial NCT02216500 study?
This clinical trial studies the following conditions: Seizures.
What interventions are being tested in trial NCT02216500?
The interventions under investigation include: Ketogenic Therapy (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02216500?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02216500 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seizures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02216500's enrollment target sits among peer trials
400 9th of 39 higher than 31 of 39 other Seizures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Seizures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Modulating Movement Intention Via Cortical Stimulation
RECRUITING · NA
-
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
RECRUITING · NA
-
Oxygen Toxicity: Mechanisms in Humans
RECRUITING · NA
-
Ear-Seizure Detection (EarSD) Study
RECRUITING · NA
-
Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
- NCT02285582 · 400 participants
International Rare Histiocytic Disorders Registry (IRHDR)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia